Global Antiemetic Drug Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	184 Pages	TechNavio	August, 2024	INF19287753

Best Price Guarantee
Price	from $2,500
Length	184 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19287753

Global Antiemetic Drug Market 2024-2028

The antiemetic drug market is forecasted to grow by USD 1723.7 mn during 2023-2028, accelerating at a CAGR of 6.48% during the forecast period. The report on the antiemetic drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population globally, growing prevalence of nausea and vomiting, and increasing healthcare expenditure.

Technavio's antiemetic drug market is segmented as below:

By Drug Class
5-Hydroxytryptamine 3
Dopamine antagonist
Neurokinin-1 (NK 1) receptor antagonist
Cannabinoid receptor antagonist
Others
By Application
Chemotherapy
Surgery
Gastroenteritis
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of digital health solutions in antiemetic drug management as one of the prime reasons driving the antiemetic drug market growth during the next few years. Also, growing number of recent developments related to antiemetic drugs and rising demand for antiemetic drugs in emerging economies will lead to sizable demand in the market.

The report on the antiemetic drug market covers the following areas:

Antiemetic drug market sizing
Antiemetic drug market forecast
Antiemetic drug market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antiemetic drug market vendors that include Algen Healthcare Ltd., Boehringer Ingelheim International GmbH, Bristol Laboratories Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., Eagle Pharmaceuticals Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the antiemetic drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Drug Class; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Antiemetic Drug Market 2018 - 2022; Historic Market Size - Data Table on Global Antiemetic Drug Market 2018 - 2022 ($ million); 4.2 Drug Class segment analysis 2018 - 2022; Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Drug Class: 6.1 Market segments; Chart on Drug Class - Market share 2023-2028 (%); Data Table on Drug Class - Market share 2023-2028 (%); 6.2 Comparison by Drug Class; Chart on Comparison by Drug Class; Data Table on Comparison by Drug Class; 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028; Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million); Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million); Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%); Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%); 6.4 Dopamine antagonist - Market size and forecast 2023-2028; Chart on Dopamine antagonist - Market size and forecast 2023-2028 ($ million); Data Table on Dopamine antagonist - Market size and forecast 2023-2028 ($ million); Chart on Dopamine antagonist - Year-over-year growth 2023-2028 (%); Data Table on Dopamine antagonist - Year-over-year growth 2023-2028 (%); 6.5 Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028; Chart on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million); Data Table on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million); Chart on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%); Data Table on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%); 6.6 Cannabinoid receptor antagonist - Market size and forecast 2023-2028; Chart on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million); Data Table on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million); Chart on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%); Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%); 6.7 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.8 Market opportunity by Drug Class; Market opportunity by Drug Class ($ million); Data Table on Market opportunity by Drug Class ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Chemotherapy - Market size and forecast 2023-2028; Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); 7.4 Surgery - Market size and forecast 2023-2028; Chart on Surgery - Market size and forecast 2023-2028 ($ million); Data Table on Surgery - Market size and forecast 2023-2028 ($ million); Chart on Surgery - Year-over-year growth 2023-2028 (%); Data Table on Surgery - Year-over-year growth 2023-2028 (%); 7.5 Gastroenteritis - Market size and forecast 2023-2028; Chart on Gastroenteritis - Market size and forecast 2023-2028 ($ million); Data Table on Gastroenteritis - Market size and forecast 2023-2028 ($ million); Chart on Gastroenteritis - Year-over-year growth 2023-2028 (%); Data Table on Gastroenteritis - Year-over-year growth 2023-2028 (%); 7.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; 12.4 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; 12.5 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 12.6 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 12.7 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.8 Helsinn Healthcare SA; Helsinn Healthcare SA - Overview; Helsinn Healthcare SA - Product / Service; Helsinn Healthcare SA - Key offerings; 12.9 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; 12.10 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.11 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.12 Otsuka Holdings Co. Ltd.; Otsuka Holdings Co. Ltd. - Overview; Otsuka Holdings Co. Ltd. - Business segments; Otsuka Holdings Co. Ltd. - Key news; Otsuka Holdings Co. Ltd. - Key offerings; Otsuka Holdings Co. Ltd. - Segment focus; 12.13 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.14 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.15 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; 12.16 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Antiemetic Drug Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Drug Class - Market share 2023-2028 (%); Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Drug Class; Exhibits35: Data Table on Comparison by Drug Class; Exhibits36: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Dopamine antagonist - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Dopamine antagonist - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Dopamine antagonist - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Dopamine antagonist - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Cannabinoid receptor antagonist - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits56: Market opportunity by Drug Class ($ million); Exhibits57: Data Table on Market opportunity by Drug Class ($ million); Exhibits58: Chart on Application - Market share 2023-2028 (%); Exhibits59: Data Table on Application - Market share 2023-2028 (%); Exhibits60: Chart on Comparison by Application; Exhibits61: Data Table on Comparison by Application; Exhibits62: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Surgery - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Surgery - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Surgery - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Surgery - Year-over-year growth 2023-2028 (%); Exhibits70: Chart on Gastroenteritis - Market size and forecast 2023-2028 ($ million); Exhibits71: Data Table on Gastroenteritis - Market size and forecast 2023-2028 ($ million); Exhibits72: Chart on Gastroenteritis - Year-over-year growth 2023-2028 (%); Exhibits73: Data Table on Gastroenteritis - Year-over-year growth 2023-2028 (%); Exhibits74: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits75: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits76: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits77: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits78: Market opportunity by Application ($ million); Exhibits79: Data Table on Market opportunity by Application ($ million); Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits83: Chart on Geographic comparison; Exhibits84: Data Table on Geographic comparison; Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits121: Market opportunity By Geographical Landscape ($ million); Exhibits122: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits123: Impact of drivers and challenges in 2023 and 2028; Exhibits124: Overview on criticality of inputs and factors of differentiation; Exhibits125: Overview on factors of disruption; Exhibits126: Impact of key risks on business; Exhibits127: Companies covered; Exhibits128: Matrix on companies position and classification; Exhibits129: Boehringer Ingelheim International GmbH - Overview; Exhibits130: Boehringer Ingelheim International GmbH - Product / Service; Exhibits131: Boehringer Ingelheim International GmbH - Key news; Exhibits132: Boehringer Ingelheim International GmbH - Key offerings; Exhibits133: Cadila Pharmaceuticals Ltd. - Overview; Exhibits134: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits135: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits136: Cipla Inc. - Overview; Exhibits137: Cipla Inc. - Business segments; Exhibits138: Cipla Inc. - Key news; Exhibits139: Cipla Inc. - Key offerings; Exhibits140: Cipla Inc. - Segment focus; Exhibits141: Fresenius SE and Co. KGaA - Overview; Exhibits142: Fresenius SE and Co. KGaA - Business segments; Exhibits143: Fresenius SE and Co. KGaA - Key news; Exhibits144: Fresenius SE and Co. KGaA - Key offerings; Exhibits145: Fresenius SE and Co. KGaA - Segment focus; Exhibits146: GlaxoSmithKline Plc - Overview; Exhibits147: GlaxoSmithKline Plc - Business segments; Exhibits148: GlaxoSmithKline Plc - Key news; Exhibits149: GlaxoSmithKline Plc - Key offerings; Exhibits150: GlaxoSmithKline Plc - Segment focus; Exhibits151: Helsinn Healthcare SA - Overview; Exhibits152: Helsinn Healthcare SA - Product / Service; Exhibits153: Helsinn Healthcare SA - Key offerings; Exhibits154: Lupin Ltd. - Overview; Exhibits155: Lupin Ltd. - Business segments; Exhibits156: Lupin Ltd. - Key news; Exhibits157: Lupin Ltd. - Key offerings; Exhibits158: Lupin Ltd. - Segment focus; Exhibits159: Merck and Co. Inc. - Overview; Exhibits160: Merck and Co. Inc. - Business segments; Exhibits161: Merck and Co. Inc. - Key news; Exhibits162: Merck and Co. Inc. - Key offerings; Exhibits163: Merck and Co. Inc. - Segment focus; Exhibits164: Novartis AG - Overview; Exhibits165: Novartis AG - Business segments; Exhibits166: Novartis AG - Key news; Exhibits167: Novartis AG - Key offerings; Exhibits168: Novartis AG - Segment focus; Exhibits169: Otsuka Holdings Co. Ltd. - Overview; Exhibits170: Otsuka Holdings Co. Ltd. - Business segments; Exhibits171: Otsuka Holdings Co. Ltd. - Key news; Exhibits172: Otsuka Holdings Co. Ltd. - Key offerings; Exhibits173: Otsuka Holdings Co. Ltd. - Segment focus; Exhibits174: Pfizer Inc. - Overview; Exhibits175: Pfizer Inc. - Product / Service; Exhibits176: Pfizer Inc. - Key news; Exhibits177: Pfizer Inc. - Key offerings; Exhibits178: Sanofi SA - Overview; Exhibits179: Sanofi SA - Business segments; Exhibits180: Sanofi SA - Key news; Exhibits181: Sanofi SA - Key offerings; Exhibits182: Sanofi SA - Segment focus; Exhibits183: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits184: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits185: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits186: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits187: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits188: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits189: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits190: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits191: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits192: Viatris Inc. - Overview; Exhibits193: Viatris Inc. - Business segments; Exhibits194: Viatris Inc. - Key news; Exhibits195: Viatris Inc. - Key offerings; Exhibits196: Viatris Inc. - Segment focus; Exhibits197: Inclusions checklist; Exhibits198: Exclusions checklist; Exhibits199: Currency conversion rates for US$; Exhibits200: Research methodology; Exhibits201: Information sources; Exhibits202: Data validation; Exhibits203: Validation techniques employed for market sizing; Exhibits204: Data synthesis; Exhibits205: 360 degree market analysis; Exhibits206: List of abbreviations